Abstract
Background
Cartilage regenerative mechanisms initiated by knee joint distraction (KJD) remain elusive. Animal experiments that are representative for the human osteoarthritic situation and investigate the effects of KJD at consecutive time points could be helpful in this respect but are lacking. This study investigated the effects of KJD on the osteoarthritic joint of dogs on two consecutive timepoints.
Methods
Osteoarthritis was bilaterally induced for 10 weeks in 12 dogs using the groove model. Subsequently, KJD was applied to the right hindlimb for 8 weeks. The cartilage, subchondral bone and synovial membrane were investigated directly after KJD treatment, and after 10 weeks of follow-up after KJD treatment. Macroscopic and microscopic joint tissue alterations were investigated using the OARSI grading system. Additionally, proteoglycan content and synthesis of the cartilage were assessed biochemically. RT-qPCR analysis was used to explore involved signaling pathways.
Results
Directly after KJD proteoglycan and collagen type II content were reduced accompanied by decreased proteoglycan synthesis. After 10 weeks of follow-up, proteoglycan and collagen type II content were partly restored and proteoglycan synthesis increased. RT-qPCR analysis of the cartilage suggests involvement of the TGF-β and Notch signalling pathways. Additionally, increased subchondral bone remodelling was found at 10 weeks of follow-up.
Conclusion
While the catabolic environment in the cartilage is still present directly after KJD, at 10 weeks of follow-up a switch towards a more anabolic joint environment was observed. Further investigation of this timepoint and the pathways involved might elucidate the regenerative mechanisms behind KJD.
The Translational Potential of this Article
Further elucidation of the regenerative mechanisms behind KJD could improve the existing KJD treatment. Furthermore, these findings could provide input for the discovery or improvement of other joint regenerative treatment strategies.
Keywords: Canine, Knee joint distraction, Mechanical loading, Proteoglycans, TGF-β signalling
1. Introduction
Knee joint distraction (KJD) is a joint preservative treatment strategy that may delay or prevent knee arthroplasty in end-stage osteoarthritis (OA) [1]. During KJD, the joint is temporarily distracted using an external fixation frame with built-in springs, while weightbearing of the leg is encouraged to allow for intermittent joint fluid pressure changes. Limited clinical studies, with relatively small sample size, provide evidence that KJD causes prolonged clinical benefit and structural improvement [1]. At one and two years of follow-up after KJD, an increased radiographic (minimum) joint space width and increased cartilage thickness on MRI were found [2]. Both the clinical and structural improvement after KJD were prolonged over time, as 48% of patients treated with KJD were not treated with total knee arthroplasty at 10 years of follow-up, with lasting cartilage changes observed by MRI [3,4]. Furthermore, at two years of follow-up, the net collagen type II (COL2) synthesis was increased [2]. Although these findings suggest tissue regeneration, direct evidence of cartilage tissue repair can only be conducted using animal studies.
KJD induced ingrowth of cartilage-like tissue in osteochondral defects in rabbits [[5], [6], [7]] and attenuated cartilage degradation and subchondral bone changes in rats with anterior cruciate ligament transection (ACLT)-induced OA [8]. However, small animal models do not resemble the human OA situation well [9]. KJD was mostly applied directly after or shortly after inflicting cartilage damage [5,6], incomparable to the gradual onset of OA in humans and KJD applied in joints with fully established OA. Furthermore, the natural repair activity of small mammals is much higher compared to humans [9], and specifically in rabbits joint loading is very different [9]. Within this context, dogs are a valuable alternative to study cartilage repair as they lack significant intrinsic ability to heal cartilage defects, similar to humans, and canine OA bears a close resemblance to human OA [10]. In a canine ACLT model, with 16 weeks of OA establishment prior to KJD treatment, synovitis decreased and the proteoglycan (PG) turnover normalized directly after 8 weeks of KJD, although no evidence for cartilage repair was identified [11]. In a canine groove model, 25 weeks follow-up after KJD, improved macroscopic and histologic damage scores, higher proteoglycan content, better retention of newly formed PG and less collagen damage were reported in KJD-treated joints compared to the OA controls [12]. It was therefore hypothesized that tissue structure modification is initiated during distraction and proceeds in the post-distraction period, resulting in the tissue repair seen in human clinical studies. However, a recent study, employing KJD 10 weeks after OA was induced with the groove model, showed that midway KJD treatment (after 4 weeks of KJD), cartilage integrity decreased [13]. This was reflected by increased histological OARSI score and upregulation of catabolic genes in the distracted joint as compared to OA joint [13].
Up until now, comprehensive animal experiments that investigate the progression of the effects of KJD at consecutive time points within one relevant animal model are lacking. Based on earlier canine studies we hypothesized that the shift towards repair activity occurs either at the end of the KJD period or in the subsequent follow-up period. Therefore, in the present study, a bilateral OA groove was employed to investigated joint tissues directly after 8 weeks of unilateral KJD, and at 10 weeks of follow-up after KJD. Combined with the studies performed in the same canine groove model of OA at an earlier and later timepoint of follow up [12,13], this explorative study provides complementary insights into the regenerative mechanisms behind KJD.
2. Methods and materials
2.1. Animals and experimental procedures
Skeletally mature mixed-breed dogs (n = 12, females, 16.1 ± 5.1 (mean ± SD) months and 20.9 ± 2.6 kg) were obtained from Marshall BioResources (North Rose, NY, USA) after ethical approval (AVD1080020173964). Extensive information about the animal husbandry and experimental procedures is described in supplementary file 1.1 and 1.2. Sample size calculation used the size effects obtained in the previous KJD study [13].
Knee OA was induced bilaterally according to the canine groove model, as described before [14]. After 10 weeks of OA induction, distraction of the right knee joint was applied for 8 weeks employing an external fixation frame with a hinge bridging the joint [12]. Joint distraction was achieved, intra-operatively visualized using fluoroscopy (Fig. 1B), maintaining smooth motion of the joint during flexion and extension. The extend of distraction and integrity of the bone pins were monitored every two weeks using radiography and adjusted if necessary.
Dogs were randomly divided in two groups. The first group (n = 4) was euthanized directly after the end of the 8-week KJD procedure. At the same timepoint, in the second group KJD was ended by removing the connecting rods and hinges to force the dogs to gradually reload the joint. The fixation frames and bone pins were removed two weeks later (Fig. 1A). The second group (n = 8) was euthanized after a 10-week follow-up period post-KJD.
2.2. Gait analysis
Limb loading was assessed using gait analysis (Fig. 1A) as described previously [15]. Briefly, vertical (Fz) and craniocaudal (Fy) forces at walking speed were measured using a force plate mounted flush with the surface of an 11-meter walkway with 100 Hz sampling frequency. The average of 10 successful recordings per limb (one measurement) was normalized to body weight and expressed in N/kg. For each timepoint, two to three measurements were performed on consecutive days.
2.3. Processing of the material
After euthanasia, both hindlimbs were processed within 2 h. High resolution photographs of the joint were obtained. Cartilage from the weight-bearing area of the femoral condyles and tibial plateaus, and patellar synovium were collected and fixed in 4% phosphate-buffered formalin containing 2% sucrose (pH 7.0) for (immuno)histochemistry or snap frozen for RNA isolation. Additionally, cartilage was collected for biochemical analysis. Subchondral bone samples were collected from the femoral condyles and tibial plateaus after the cartilage was collected, resulting in an osteochondral bone piece with a variable layer of cartilage. Subsequently, subchondral bone samples were fixed in 4% neutral buffered formaldehyde and decalcified using 0.5 M EDTA (pH 7.0; 108,421, Merck).
2.4. Macroscopic, microscopic and biochemical outcome measures
Macroscopic scoring of cartilage damage and synovial inflammation, and microscopic scoring of cartilage, synovium and subchondral bone alterations were performed randomized and blind according to the Osteoarthritis Research Society International (OARSI) canine scoring system [16] by three observers to determine the average OARSI score for each parameter. Cartilage and subchondral bone sections were stained with Safranin-O/Fast green. Synovium sections were stained with Hematoxylin/Eosin (HE). Furthermore, the cartilage matrix was evaluated for the immunopositivity of collagen type-1 (COL1A1), and −2 (COL2A1) (Supplementary file 1.3.1). Proteoglycan synthesis was determined using 35SO42−, as described previously [12] (Supplementary file 1.3.2). Briefly, after 4 h of labeling with Na235SO4 (NEX-041-H, carrier free, Dupont) and a subsequent 3-day culture period, cartilage was digested and labelled proteoglycans were precipitated using cetylpyridium chloride (CPC; Sigma C-9002) measured by liquid scintillation analysis (TriCarb, Perkin Elmer). Proteoglycans were precipitated and stained by Alcian Blue (Sigma A5268) in either tissue digest or culture medium, to determine the proteoglycan content or release. The staining was quantified spectrophotometrically according to change in absorbance at 620 nm. Chondroitin sulphate (Sigma C4383) was used as a reference.
For Alkaline phosphatase (ALP) activity, homogenized subchondral bone powder was dissolved in Tris–HCl+2% Triton (1:1) solution and ALP was measured using a p-nitrophenyl phosphate assay and normalized for DNA content measured using the Qubit™ dsDNA BR Assay. (Supplementary file 1.3.4).
2.5. Gene expression analysis by RT-qPCR
A mikro-dismembrator (B. Braun Biotech International) was used to reduce snap-frozen cartilage samples and subchondral bone plugs to powder (two cycles; 2000 rpm). After lysis with QIAzol Lysis Reagent (79,306, Qiagen) total RNA was extracted and quantified as described previously [13] (Supplementary file 1.3.3).
Quantitative RT-PCR was performed using IQ SYBR Green SuperMix (Biorad) and a CFX384 Touch™ Real-Time PCR Detection System (Biorad). 7 reference genes were employed: RPS19, SDHA, YWHAZ, TBP, RPS5, RPL13 and HPRT. When the average Cq of the references genes was higher than 35 samples were excluded considering them of insufficient quality. Relative gene expression was calculated using the Livak method (2^−ΔΔCq).
2.6. Synovial fluid analysis
Synovial fluid (SF) was aseptically collected from both stifle joints at baseline, at 10 weeks after OA induction, at 18 and 28 weeks (Fig. 1A). The SF was kept on ice and immediately processed by centrifugation (5 min, 500 g, 4 °C) to remove cellular debris, aliquoted and stored at −80 °C until further processing. SF samples were treated with hyaluronidase (1:1, final concentration 4 mg/ml, Sigma) and subjected to a canine multiplex ELISA (CCYTOMAG-90 K, Merck) to measure interleukin (IL)-6, −8, −10, −15, −18 and C–C Motif Chemokine Ligand 2 (CCL2) according to the manufacturer's protocol on a Luminex analyser (MAGPIX®, Luminex Corporation). TGFβ1 was measured in acid activated SF, without hyaluronidase treatment, using the TGF-beta 1 Quantikine ELISA Kit (MB100B, R&D Systems, Inc.) according to the manufacturer's protocol. +
2.7. Statistical analysis
Statistical analysis was performed using R Statistics (R version 3.6.3, RStudio version 1.2.5033) (Supplementary file 1.4). For normally distributed data, linear mixed models were employed. If the data was not normally distributed, a Kruskal–Wallis test and Dunn's Multiple Comparison Test were used. P values were subjected to corrections for multiple testing (Benjamini-Hochberg False Discovery Rate) if applicable (Supplementary file 1.4.). Effect sizes (ES) with 95% confident intervals (CI) were calculated using Hedge's g (HG) for normally distributed data and Cliff's delta (CD) for non-normally distributed data. Because of the explorative nature of the study, outcomes with a p value of <0.05 or p < 0.15 in combination with a large effect size (HG > 0.8, CD > 0.47) were considered relevant for discussion.
3. Results
3.1. Animals
During the OA induction phase, all dogs were fully active with subjectively normal joint loading and movement. Minor adverse effects were observed that resolved with appropriate treatment (Supplementary file 2).
3.2. Gait analysis
Directly after KJD, the peak vertical force (PVF) of OA + KJD-limbs was significantly decreased compared to OA-limbs (p < 0.001), and compared to all other time points in OA + KJD-limbs (p < 0.001) (Fig. 1C). In OA-limbs the PVF increased directly after KJD compared to 9 weeks (p = 0.02) suggesting a load shift directly after KJD treatment to compensate for the decreased loading of the OA + KJD-limb. This shift was not detected after follow-up.
3.3. Macroscopic assessment of cartilage damage and synovial inflammation
Directly after KJD, there were no differences in macroscopic cartilage damage between OA + KJD joints and OA controls (Fig. 2A and B). After follow-up, the OARSI score of OA + KJD joints was higher compared to OA controls (p = 0.009; ES (CD): 0.67) in the tibia. During tissue collection, we observed that in the OA control joints of 5/12 animals, the grooves were situated in the patellar groove instead of on the weight bearing surface of the femoral condyles (OARSI score of 0 (Fig. 2B)). A sensitivity assay (Supplementary file 2.1) demonstrated that these joints behaved in similar fashion to all other OA joints and the data was included in this and further analysis.
Macroscopic synovial inflammation was generally low directly after KJD in both joints (Fig. 2A and C) and increased at follow-up in the OA controls (p = 0.09; ES (HG): 0.8). At follow-up, in OA + KJD joints synovial inflammation increased compared to OA + KJD joints directly after KJD (p = 0.001; ES (HG): 3.44) and to OA joints at follow-up (p = 0.07; ES (HG): 0.83).
3.4. Histological evaluation of cartilage alterations
Directly after KJD in the femur and tibia there was reduced safranin O intensity, indicating loss of PG, and reduced COL2 immunopositivity in OA + KJD joints compared to OA controls (Fig. 3A). The total OARSI score increased in the OA + KJD treated tibia compared to the OA tibia at follow-up (p = 0.004; ES: 1.92)). The OARSI subscores, “PG” (p = 0.002; ES (HG): 5.1) and “collagen pathology” (p = 0.11, ES (HG): 1.35) were worse in the OA + KJD femur compared to OA controls directly after KJD (Fig. 3B). At follow-up, these subscores in the OA + KJD femur improved compared to directly after KJD (p = 0.001; ES (HG): 2.6, and p = 0.13; ES (HG): 0.88, respectively), although the “PG” subscore was still worse compared to the OA controls at follow-up (p = 0.02; ES (HG): 0.97) (Fig. 3B). Interestingly, the “chondrocyte pathology” subscore was increased in the OA + KJD tibia at follow-up compared to OA controls (p = 0.002; ES (HG): 1.7) and compared to the OA + KJD tibia directly after KJD (p = 0.04; ES (HG): 1.1). This increase was mainly related to an increase in the “chondrocyte cluster formation” subscore (Fig. 3B).
3.5. Biochemical evaluation of cartilage alterations
Biochemical outcomes of the cartilage were in line with its histological evaluation. Directly after KJD treatment, PG content was decreased in the OA + KJD femur (p < 0.001; ES (HG): 5.87) compared to OA controls (Fig. 4A). This difference in PG content was lost, as the tibia and femur revealed higher PG-content in OA + KJD joints at follow-up compared to OA + KJD joints directly after KJD (tibia; p = 0.09, ES (HG): 1.36, femur; p < 0.001; ES (HG): 4.57). However, this improved PG content was in the femur still lower compared to OA controls (p = 0.001; ES (HG): 1.4).
A similar pattern was seen for PG synthesis: it was decreased directly after KJD in the OA + KJD tibia (p = 0.0001, ES (HG): 0.99) and femur (p = 0.02, ES (HG): 6.3) compared to their OA control (Fig. 4B). At follow-up, PG synthesis increased in the OA + KJD tibia (p = 0.001, ES (HG): 1.91) and femur (p = 0.001, ES (HG): 2.38) compared to directly after KJD. In the tibia, this increased PG synthesis of the OA + KJD joints at follow-up was even higher compared to OA controls (p = 0.047, ES (HG): 0.5).
PG release, expressed as the percentage of Proteoglycans released in the medium (and normalized to the PG content), was increased in the OA + KJD tibia and femur directly after KJD compared to OA controls (tibia; p = 0.02; ES (HG): 0.87, femur; p = 0.03, ES (HG): 1.37) (Fig. 4C). At follow-up, PG release decreased in the OA + KJD femur compared to directly after KJD (p = 0.001, ES (HG): 2.54) becoming comparable to the PG release of OA joints.
3.6. RT-qPCR analysis of the TGF-β and Notch signalling pathways
RT-qPCR focused on OA-related transforming growth factor β (TGF-β) and Notch signalling pathways (Fig. 5) previously shown to be regulated during KJD [13]. Directly after KJD, in the OA + KJD joints compared to OA controls TGFβ1 expression was decreased (p = 0.03; ES (HG): 1.12). In parallel PAI1, a well-defined downstream target of TGFβ signalling [17], was increased (p = 0.12; ES (HG): 1.51), while ID1, a downstream target gene of BMP signalling, was decreased (p = 0.12; ES (HG): 0.84). At follow-up, TGFβ1 was increased in OA + KJD joints compared to OA + KJD joints directly after KJD (p = 0.10; ES (HG): 1.21). Furthermore, in OA + KJD joints bone morphogenetic protein 2 (BMP-2) (p = 0.10, ES (HG): 1.38), BMP-6 (p = 0.10, ES (HG): 1.7) and ID1 (p = 0.10, ES (HG): 1.93) increased at follow-up compared to directly after KJD. In OA + KJD joints, Notch1, a cartilage progenitor marker, was increased directly after KJD (p = 0.14, ES (HG): 1.16) compared to follow-up. Notch4, upregulated in human OA joints [18], decreased significantly over time in OA joints (p = 0.03, ES (HG): 1.39) and OA + KJD joints (p = 0.003, ES (HG): 3.49).
3.7. Evaluation of subchondral bone alterations
Subchondral bone samples contained also the deep cartilage layer. OARSI scoring of Safranin-O/Fast green stained sections showed substantial variations in tidemark integrity and subchondral bone thickness scores (Fig. 6A and B). Directly after KJD, the “tidemark integrity” subscore of the OA + KJD femur was increased compared to OA controls (p = 0.13, ES (HG): 1.38) and compared to OA + KJD joints at follow-up (p = 0.03, ES (HG): 1.78), the latter resulting in an increased total OARSI score of the OA + KJD femur at follow-up (p = 0.13, ES (HG): 1.07) (Fig. 6B).
In order to further assist in interpretation of the histological scoring which was limited by the measured variability and evaluation in a 2D plane, ALP activity was measured, and gene expression analysis was conducted (Fig. 6C and D). The ALP/DNA concentration was increased in OA + KJD joints compared to OA controls directly after KJD (p = 0.02; ES (HG): 1.41) and at follow-up (p < 0.001; ES (HG): 1.25). Osteocalcin and ALP expression, as a measure of bone formation and remodelling, were increased in OA + KJD joints at follow-up compared to OA + KJD joints directly after KJD (Osteocalcin; p < 0.001; ES (CD): 0.978, ALP; p = 0.001; ES (CD): 0.91), while the expression of osteopontin was decreased (p = 0.002; ES (CD): 0.80). MMP13 gene expression, as a measure of collagen degradation, was decreased in OA + KJD joints at follow-up compared to OA + KJD joints directly after KJD (p < 0.001; ES (CD): 1.0).
3.8. Microscopic evaluation of synovial inflammation and synovial fluid analysis
HE-stained synovial sections were evaluated using the OARSI scoring system (Fig. 7A and B). Directly after KJD, the “Lining characteristics” subscore was lower in OA + KJD joints compared to OA controls (p = 0.08; ES (HG): 1.19) and OA + KJD joints at follow-up (p = 0.06; ES (HG): 1.01) (Fig. 7B). The number of cells in the lining, “Lining Cells” subscore, was increased at follow-up in OA controls compared to OA + KJD joints (p = 0.04; ES (HG): 0.99).
Of the cytokines and chemokines measured by the Multiplex ELISA, only IL-6, IL-8 and CCL2 were detected in >50% of the SF samples. IL-6 was undetectable in the healthy baseline SF samples. Directly after KJD, IL-6 levels were lower in OA + KJD compared to OA SF (p = 0.086, ES (CD): 0.8) (Fig. 8A). At follow-up, IL-8 was higher in OA + KJD compared to OA SF (p = 0.13, ES (HG): 0.91) (Fig. 8B). At all timepoints, CCL2 levels of the OA and OA + KJD SF was higher compared to healthy baseline samples (p < 0.05) (Fig. 8C). The highest CCL2 levels were found in OA + KJD joints at follow-up, being higher compared to the healthy baseline (p < 0.001, ES (HG): 2.69) and OA (10 weeks) SF (p = 0.007, ES (HG): 1.26). The concentration of TGFβ1 increased after OA induction (p = 0.012, ES (HG): 1.13) compared to the healthy baseline. Directly after KJD treatment, TGFβ1 levels were higher in OA + KJD compared to the OA control at the same timepoint (p = 0.022, ES (HG): 1.81).
4. Discussion
The present explorative study describes the dynamical changes at the cartilage, subchondral and synovial level that are associated with KJD and contributes to current concepts of how KJD elicits a reparative response seen on the long term [1].
At the structural level, the present study observed decreased PG and COL2 content directly after KJD which is in line with recent findings showing loss of PG and COL2 in the OA + KJD joint midway distraction treatment [13]. Similar findings were also reported directly after KJD in a canine ACLT OA model [11]. This PG depletion is caused by a combination of decreased PG synthesis and increased release of PGs in the presence of increased matrix degrading enzymes, such as MMPs and ADAMTS5 [13]. These changes are most probably induced by the absence of normal loading during the KJD period. Unloading due to immobilisation or continuous joint distraction was shown to decrease PG content and synthesis in the healthy cartilage [[19], [20], [21], [22], [23]]. In addition, modest changes in the collagenous matrix of the immobilised cartilage have been reported, with a ∼13% reduction of collagen crosslinking [23]. In line with this thought, the loss of PG and COL2 content seen directly after KJD, is partially reversed after 10 weeks of follow-up where the animals are allowed to load their joints, and is mostly due to an increased PG synthesis. Correspondingly, cyclic compression increases PG synthesis in cartilage explants [24] and remobilization after joint immobilization leads to (partial) recovery of the cartilage PG content [21,23].
These observations raise the question how these changes in the cartilaginous matrix, seen during and after KJD, ultimately lead to the cartilage regenerative responses seen at prolonged follow-up in the canine experimental study [12], the small animal studies [[5], [6], [7], [8]], and the clinical studies in humans [2]. During OA, a vicious circle occurs, starting with the deterioration of the cartilaginous matrix, resulting in PG loss, increased collagen crosslinking and altered molecular organization [25]. As the mechanoprotective properties of the degenerate cartilage are lost, normal loading of the joint results in OA progression [21]. This circle is further maintained by the limited intrinsic reparative capacity of cartilage [26,27]. During KJD, the mechanical loading of the joint is decreased, causing further matrix degradation and advancement of the tidemark [21,28]. Under these conditions, it is tempting to hypothesize that this matrix degradation facilitates KJD-related repair in two manners: (a) improper matrix components due to OA are removed [29], and (2) sequestered heparan sulfate-bound molecules of the pericellular matrix, such as TGFβ1 and fibroblast growth factor 2 (FGF2) are released [21,29]. These biomolecules have both been found to be upregulated in the SF of human patients during KJD treatment [30] and in the present study TGFβ1 was upregulated in the OA + KJD directly after KJD treatment compared to the OA control. Activated TGFβ signalling is also reflected in the increased expression of PAI1 at the cartilage level, a downstream mediator of TGFβ1 signalling, in KJD-treated joints compared to OA controls directly after treatment, even though TGFβ1 mRNA levels were downregulated. These changes indicated that the altered TGF signaling may contribute to the restoration to the joint homeostasis. Release of these biomolecules through matrix degradation could also induce pathways related to cartilage reparative responses. Altogether, this implies that the (partial) unloading during KJD initiates a catabolic environment, allowing for essential remodeling of the cartilage. Combined with the return of the loading after the KJD, these changes in the cartilage homeostasis provide an anabolic environment that promotes the subsequent successful cartilage repair activity.
In parallel to the matrix changes, increased chondrocyte cluster formation in the KJD-treated joints at follow-up was observed. Traditionally, an increase in cluster formation is recognized as a hallmark of OA [16]. However, chondrocyte clusters produce anabolic factors and express progenitor cell markers [31]. Indeed, both during [13] and directly after KJD treatment, Notch1, a cartilage progenitor cell marker [32], was upregulated in KJD-treated joints compared to OA controls. In line with this hypothesis, the released FGF2 and TGFβ1 due to the increased matrix remodelling could facilitate chondrocyte progenitor activation, proliferation and subsequent differentiation [21,29,33].
The effects of decreased loading and remobilisation upon removal of the KJD are also reflected at the subchondral bone level. This is corroborated by the changes in the tidemark integrity [28] and the increased (subchondral) bone remodelling at follow-up, as demonstrated by an increase in ALP and osteocalcin, indicating the presence of active osteoblasts [34]. The increased bone remodelling corresponds with the effects of distraction on the ankle joint in human patients in which a decreased subchondral bone density was found in sclerotic areas and an increased density in cystic lesions, resulting in an overall normalization of bone density after distraction treatment [35]. This increase in bone density in the cystic lesions might explain the decrease in pain in patients treated with distraction, as subchondral bone cysts are associated with nerve ingrowth and pain [36]. Furthermore, the effect of mechanical loading on bone is well known; once the mechanical load changes, the turnover rate of subchondral bone adjusts to adapt [37]. Notably, the insertion of the bone pins, without actual distraction, had already cartilage regenerative effects on the OA cartilage of dogs [12]. As the existence of direct molecular signalling linking cartilage and subchondral bone has been proven, the effect of this crosstalk during KJD should not be excluded [37].
The OA environment in the canine grooved joint, is reflected in the mild synovitis score on histology and the upregulated CCL2 and IL-6 SF levels in OA and KJD-treated joints compared to their healthy baseline [38]. Directly after KJD synovitis seemed to be improved based on reduced villi formation and reduced SF IL-6 levels compared to OA controls. However, there was substantial variation in IL-6 levels in the KJD joints and IL-6 levels were in only two samples detectable in the OA joint. Therefore, these results should be interpreted with caution. Interestingly, at follow-up synovitis increased again evidenced at the macroscopic and microscopic level and the increased SF IL-8 and CCL2 levels. In line with this, Watt et al. (2020), reported increased CCL2 SF levels directly after-, and increased IL-8 SF levels during KJD treatment [30]. In general, increased CCL2 and IL-8 levels are associated with OA severity [39]. The question remains however whether the synovitis found in the follow-up contributes to or is a reflection of the degenerative cartilage changes. A more detailed investigation into the phenotypic changes of the synoviocytes could provide clues into the role of the synovial membrane during KJD.
The small number of animals resulted in a high variance of parameters such as the gene expression analysis, compromising the study power of these results. Therefore, the obtained insights require further in dept investigation with a larger sample size and results should be interpreted carefully. Furthermore, technical problems arose in this study such as the high bone pin failure rate. Although no problems in the bone pin material could be identified, to prevent this future studies using the canine KJD model should reconsider the stiffness of the construction.
Joint distraction provides a biochemical and biomechanical environment that facilitates regeneration of the joint. However, it is an demanding treatment with 6–9 weeks of partial joint immobilization, and entails a high risk of skin pin-tract infections [1]. More importantly, for a group of people, joint distraction is only a temporary solution that delays the OA progression, with a clear influence of patient characteristics on the overall effect [40]. This study contributes to further elucidation of the mechanisms behind joint distraction. This could help improve the existing KJD treatment or help with patient selection. For example, based on the results of this study it could be hypothesized that patients with osteoarthritis characterized by cartilage damage or altered cartilage and bone metabolism might benefit more from KJD treatment than patients with OA characterized by chronic pain [41]. Furthermore, these insights into joint and cartilage regeneration might result in the discovery or improvement of disease modifying OA drugs (DMOADs) or other cartilage regenerative approaches [42]. These treatments could also be combined with KJD treatment. However, as we found in this study that the effect of KJD treatment consists of a catabolic and anabolic phase, it is important to consider the mode of action of the applied DMOAD and the right time frame for its application. Finally, as the dog is not only a suitable animal model for OA but also a species that suffers from spontaneous OA [10], the techniques optimized for this animal model could be applied to treat dogs with OA. KJD has been shown to be a feasible treatment strategy for dogs with severe end-stage OA, although efficacy has to be proven in larger clinical studies [15].
5. Conclusions
During KJD there is a catabolic environment, characterized by a loss of PG and COL2 content and a decrease in PG synthesis. This preceding cartilage degradation may remove the deteriorated osteoarthritic matrix and free growth factors sequestered in the matrix. Upon restoration of joint loading, at 10 weeks of follow-up, PG and COL2 content and PG synthesis increase, demonstrating a switch towards an anabolic joint environment. Gene expression analysis of the cartilage suggests the involvement of the TGF and Notch signalling pathways. Concurrent subchondral bone remodelling may contribute to the regenerative effects of KJD.
Funding/support statement
This project was financially supported by the Dutch Arthritis Society (LLP9 and LLP22) and NWO Domain Applied and Engineering Sciences (AES) (P15-23). There is no further involvement in the present work of the abovementioned sources.
Author statement
BPM, FPJGL, MAT and SCM obtained the funding for this study. MT, BPM, FB, FPJGL, MAT and SCM contributed to the conception and design of the study. MT, BPM, LS, KC, JPC, ISL, FPJGL, MAT and SCM contributed to the experimental procedures, and collection and assembly of the data. LS, KC and ISL provided technical and logistic support during the study. MT, BPM, FPJGL, MAT and SCM contributed to the analysis and interpretation of the data. All authors contributed to drafting of the article and helped revising it critically for intellectual content. All authors approved the final version of this article for submission.
Declaration of competing interest
FPJGL is consultant as UMCU employee for Synerkine Pharma BV and co-founder of ArthroSave BV without further relations. All authors declare that there is no conflict of interest.
Acknowledgements
The authors would like to thank P.M. Roermund for his assistance during application of the distraction device in the in vivo experiment. Furthermore, the authors would like to thank Arie Doornebal for his assistance with the force plate analysis, and Harry van Engelen, Jeroen van Ark, Helma Avezaat and Nico Attevelt for their assistance with the experimental animals.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jot.2022.09.003.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Jansen M.P., Mastbergen S.C. Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms. Nat Rev Rheumatol. 2021:1–12. doi: 10.1038/S41584-021-00695-Y. [DOI] [PubMed] [Google Scholar]
- 2.Jansen M.P., Besselink N.J., van Heerwaarden R.J., Custers R.J.H., Emans P.J., Spruijt S., et al. Knee joint distraction compared with high tibial osteotomy and total knee arthroplasty: two-year clinical, radiographic, and biochemical marker outcomes of two randomized controlled trials. Cartilage. 2021;12:181–191. doi: 10.1177/1947603519828432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jansen M., Mastbergen S.C., Turmezei T.D., MacKay J.W., Lafeber F.P. Knee joint distraction results in MRI cartilage thickness increase up to ten years after treatment. Osteoarthritis Cartilage. 2021;29:S331–S332. doi: 10.1016/J.JOCA.2021.02.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jansen M.P., Boymans T.A.E.J., Custers R.J.H., Van Geenen R.C.I., Van Heerwaarden R.J., Huizinga M.R., et al. Knee joint distraction as treatment for osteoarthritis results in clinical and structural benefit: a systematic review and meta-analysis of the limited number of studies and patients available. Cartilage. 2020 doi: 10.1177/1947603520942945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kajiwara R., Ishida O., Kawasaki K., Adachi N., Yasunaga Y., Ochi M. Effective repair of a fresh osteochondral defect in the rabbit knee joint by articulated joint distraction following subchondral drilling. J Orthop Res. 2005;23:909–915. doi: 10.1016/j.orthres.2004.12.003. [DOI] [PubMed] [Google Scholar]
- 6.Yanai T., Ishii T., Chang F., Ochiai N. Repair of large full-thickness articular cartilage defects in the rabbit. The effects of joints distraction and autologous bone-marrow-derived mesenchymal cell transplantation. J Bone Joint Surg. 2005;87:721–729. doi: 10.1302/0301-620X.87B5.15542. [DOI] [PubMed] [Google Scholar]
- 7.Sun Z.B., Peng H. Experimental study on the prevention of posttraumatic osteoarthritis in the rabbit knee using a hinged external fixator in combination with exercises. J Invest Surg. 2019;32:552–559. doi: 10.1080/08941939.2018.1543483. [DOI] [PubMed] [Google Scholar]
- 8.Chen Y., Sun Y., Pan X., Ho K., Li G. Joint distraction attenuates osteoarthritis by reducing secondary inflammation, cartilage degeneration and subchondral bone aberrant change. Osteoarthritis Cartilage. 2015;23:1728–1735. doi: 10.1016/j.joca.2015.05.018. [DOI] [PubMed] [Google Scholar]
- 9.Chu C.R., Szczodry M., Bruno S. Animal models for cartilage regeneration and repair. Tissue Eng B Rev. 2010;16:105–115. doi: 10.1089/ten.teb.2009.0452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Meeson R.L., Todhunter R.J., Blunn G., Nuki G., Pitsillides A.A. Spontaneous dog osteoarthritis — a One Medicine vision. Nat Rev Rheumatol. 2019;15:273–287. doi: 10.1038/s41584-019-0202-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Van Valburg A.A., Van Roermund P.M., Marijnissen A.C.A., Wenting M.J.G., Verbout A.J., Lafeber F.P.J.G., et al. Joint distraction in treatment of osteoarthritis (II): effects on cartilage in a canine model. Osteoarthritis Cartilage. 2000;8:1–8. doi: 10.1053/joca.1999.0263. [DOI] [PubMed] [Google Scholar]
- 12.Wiegant K., Intema F., Van Roermund P.M., Barten-Van Rijbroek A.D., Doornebal A., Hazewinkel H.A.W., et al. Evidence of cartilage repair by joint distraction in a canine model of osteoarthritis. Arthritis Rheumatol. 2015;67:465–474. doi: 10.1002/art.38906. [DOI] [PubMed] [Google Scholar]
- 13.Teunissen M., Miranda Bedate A., Coeleveld K., Riemers F.M., Meij B.P., Lafeber F.P.J.G., et al. Enhanced Extracellular Matrix Breakdown Characterizes the Early Distraction Phase of Canine Knee Joint Distraction. Cartilage. 2021 Dec;13(2_suppl):1654S–1664S. doi: 10.1177/19476035211014595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Intema F., DeGroot J., Elshof B., Vianen M.E., Yocum S., Zuurmond A., et al. The canine bilateral groove model of osteoarthritis. J Orthop Res. 2008;26:1471–1477. doi: 10.1002/jor.20681. [DOI] [PubMed] [Google Scholar]
- 15.Teunissen M., Mastbergen S.C., Spoelman D.C., Lafeber F.P., Ludwig I.S., Broere F., et al. Knee joint distraction in a dog as treatment for severe osteoarthritis. VCOT Open. 2022;5 doi: 10.1055/s-0042-1742471. [DOI] [Google Scholar]
- 16.Cook J.L., Kuroki K., Visco D., Pelletier J.P., Schulz L., Lafeber F.P.J.G. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the dog. Osteoarthritis Cartilage. 2010;18:S66–S79. doi: 10.1016/j.joca.2010.04.017. [DOI] [PubMed] [Google Scholar]
- 17.Rabieian R., Boshtam M., Zareei M., Kouhpayeh S., Masoudifar A., Mirzaei H. Plasminogen activator inhibitor type-1 as a regulator of fibrosis. J Cell Biochem. 2018;119:17–27. doi: 10.1002/jcb.26146. [DOI] [PubMed] [Google Scholar]
- 18.Mahjoub M., Sassi N., Driss M., Laadhar L., Allouche M., Hamdoun M., et al. Expression patterns of Notch receptors and their ligands in human osteoarthritic and healthy articular cartilage. Tissue Cell. 2012;44:182–194. doi: 10.1016/j.tice.2012.03.001. [DOI] [PubMed] [Google Scholar]
- 19.Hung S.C., Nakamura K., Shiro R., Tanaka K., Kawahara H., Kurokawa T. Effects of continuous distraction on cartilage in a moving joint: an investigation on adult rabbits. J Orthop Res. 1997;15:381–390. doi: 10.1002/jor.1100150310. [DOI] [PubMed] [Google Scholar]
- 20.Haapala J., Arokoski J., Pirttimäki J., Lyyra T., Jurvelin J., Tammi M., et al. Incomplete restoration of immobilization induced softening of young beagle knee articular cartilage after 50-week remobilization. Int J Sports Med. 2000;21:76–81. doi: 10.1055/s-2000-8860. [DOI] [PubMed] [Google Scholar]
- 21.Vincent T.L., Wann A.K.T. Mechanoadaptation: articular cartilage through thick and thin. J Physiol. 2019;597:1271–1281. doi: 10.1113/JP275451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Palmoski M.J., Brandt K.D. Running inhibits the reversal of atrophic changes in canine knee cartilage after removal of a leg cast. Arthritis Rheum. 1981;24:1329–1337. doi: 10.1002/art.1780241101. [DOI] [PubMed] [Google Scholar]
- 23.Haapala J., Arokoski J.P.A., Hyttinen M.M., Lammi M., Tammi M., Kovanen V., et al. Remobilization does not fully restore immobilization induced articular cartilage atrophy. Clin Orthop Relat Res. 1999;218–29 doi: 10.1097/00003086-199905000-00031. [DOI] [PubMed] [Google Scholar]
- 24.Arokoski J.P.A., Jurvelin J.S., Väätäinen U., Helminen H.J. Normal and pathological adaptations of articular cartilage to joint loading. Scand J Med Sci Sports. 2000;10:186–198. doi: 10.1034/j.1600-0838.2000.010004186.x. [DOI] [PubMed] [Google Scholar]
- 25.Heinegård D., Saxne T. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol. 2011;7:50–56. doi: 10.1038/nrrheum.2010.198. [DOI] [PubMed] [Google Scholar]
- 26.Simon T.M., Jackson D.W. Articular cartilage: injury pathways and treatment options. Sports Med Arthrosc Rev. 2018;26:31–39. doi: 10.1097/JSA.0000000000000182. [DOI] [PubMed] [Google Scholar]
- 27.Correa D., Lietman S.A. Articular cartilage repair: current needs, methods and research directions. Semin Cell Dev Biol. 2017;62:67–77. doi: 10.1016/j.semcdb.2016.07.013. [DOI] [PubMed] [Google Scholar]
- 28.O'Connor K.M. Unweighting accelerates tidemark advancement in articular cartilage at the knee joint of rats. J Bone Miner Res. 1997;12:580–589. doi: 10.1359/jbmr.1997.12.4.580. [DOI] [PubMed] [Google Scholar]
- 29.Vincent T.L. Mechanoflammation in osteoarthritis pathogenesis. Semin Arthritis Rheum. 2019;49:S36–S38. doi: 10.1016/j.semarthrit.2019.09.018. [DOI] [PubMed] [Google Scholar]
- 30.Watt F.E., Hamid B., Garriga C., Judge A., Hrusecka R., Custers R.J.H., et al. The molecular profile of synovial fluid changes upon joint distraction and is associated with clinical response in knee osteoarthritis. Osteoarthritis Cartilage. 2020;28:324–333. doi: 10.1016/j.joca.2019.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hoshiyama Y., Otsuki S., Oda S., Kurokawa Y., Nakajima M., Jotoku T., et al. Chondrocyte clusters adjacent to sites of cartilage degeneration have characteristics of progenitor cells. J Orthop Res. 2015;33:548–555. doi: 10.1002/jor.22782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Grogan S.P., Miyaki S., Asahara H., D'Lima D.D., Lotz M.K. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res Ther. 2009;11:R85. doi: 10.1186/ar2719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Khan I.M., Palmer E.A., Archer C.W. Fibroblast growth factor-2 induced chondrocyte cluster formation in experimentally wounded articular cartilage is blocked by soluble Jagged-1. Osteoarthritis Cartilage. 2010;18:208–219. doi: 10.1016/j.joca.2009.08.011. [DOI] [PubMed] [Google Scholar]
- 34.Rucci N. Molecular biology of bone remodelling. Clinical Cases Min Bone Metabol. 2008;5:49–56. [PMC free article] [PubMed] [Google Scholar]
- 35.Intema F., Thomas T.P., Anderson D.D., Elkins J.M., Brown T.D., Amendola A., et al. Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis Cartilage. 2011;19:668–675. doi: 10.1016/j.joca.2011.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zhou F., Han X., Wang L., Zhang W., Cui J., He Z., et al. Associations of osteoclastogenesis and nerve growth in subchondral bone marrow lesions with clinical symptoms in knee osteoarthritis. J Orthop Translat. 2022;32 doi: 10.1016/j.jot.2021.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hu Y., Chen X., Wang S., Jing Y., Su J. Subchondral bone microenvironment in osteoarthritis and pain. Bone Res. 2021;9:1–13. doi: 10.1038/s41413-021-00147-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Allen P.I., Conzemius M.G., Evans R.B., Kiefer K. Correlation between synovial fluid cytokine concentrations and limb function in normal dogs and in dogs with lameness from spontaneous osteoarthritis. Vet Surg. 2019;48:A002. doi: 10.1111/vsu.13212. [DOI] [PubMed] [Google Scholar]
- 39.Kleine S.A., Gogal R.M., George C., Thaliath M., Budsberg S.C. Elevated synovial fluid concentration of monocyte chemoattractant protein-1 and interleukin-8 in dogs with osteoarthritis of the stifle. Vet Comp Orthop Traumatol. 2020;33:147–150. doi: 10.1055/s-0039-3399525. [DOI] [PubMed] [Google Scholar]
- 40.Jansen M.P., van der Weiden G.S., van Roermund P.M., Custers R.J.H., Mastbergen S.C., Lafeber F.P.J.G. Initial tissue repair predicts long-term clinical success of knee joint distraction as treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2018;26:1604–1608. doi: 10.1016/j.joca.2018.08.004. [DOI] [PubMed] [Google Scholar]
- 41.Dell'Isola A., Allan R., Smith S.L., Marreiros S.S.P., Steultjens M. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Muscoskel Disord. 2016;17:1–12. doi: 10.1186/S12891-016-1286-2/TABLES/4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Mastbergen S.C., Saris D.B.F., Lafeber F.P.J.G. Functional articular cartilage repair: here, near, or is the best approach not yet clear? Nat Rev Rheumatol. 2013;9:277–290. doi: 10.1038/nrrheum.2013.29. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.